 Jounce Therapeutics, Inc. NASDAQ:JNCE Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Eric Laub - Vice President-Investor Relations Richard Murray - Chief Executive Officer President Beth Trehu - Chief Medical Officer Dmitri Wiederschain - Chief Scientific Officer Kim Drapkin - Chief Financial Officer Conference Call Participants Edward Tenthoff - Piper Sandler Boris Peaker - Cowen Steven Seedhouse - Raymond James David Dai - SMBC Swayampakula Ramakanth - HCW Nick Abbott - Wells Fargo Operator Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Second Quarter -- 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. 